Jury awards plaintiff $482 mln in J&J stent battle
NEW YORK (Reuters) - A federal jury in Texas has rendered a $482 million verdict against Johnson & Johnson, finding its widely used Cypher stent infringes on the patent of an outside researcher, the company said on Friday.
Dr. Bruce Saffran filed the lawsuit, saying that his stent patent was valid and that the healthcare company infringed on it.
J&J said the company disagrees with the jury's decision, and will fight it.
"We will ask the judge to overturn this verdict and if unsuccessful, we plan to appeal the verdict," a J&J spokesperson said.
Saffran's law firm, Dickstein Shapiro LLP, in a release, said the jury deliberated for two hours before returning its verdict.
The law firm said another federal jury in the same Marshall, Texas, courthouse three years ago rendered a $431.9 million verdict against Boston Scientific Corp, finding that its Taxus stent also infringed Saffran's patent.
(Reporting by Ransdell Pierson. Editing by Robert MacMillan)
- Malaysian plane presumed crashed; questions over false IDs |
- CORRECTED-UPDATE 4-Malaysia Airlines plane crashes in South China Sea with 239 people aboard - report
- China draws 'red line' on North Korea, says won't allow war on peninsula
- Warning shots fired to turn monitors back from Crimea |
- Malaysian plane crashed off Vietnam coast: state media